Isthmus Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-135
Closed -$8K 219
2021
Q2
$8K Buy
+135
New +$8.56K ﹤0.01% 245
2019
Q2
Sell
-3,297
Closed -$274K 180
2019
Q1
$274K Buy
+3,297
New +$146K 0.07% 129
2018
Q4
Sell
-135
Closed -$6K 226
2018
Q3
$6K Hold
135
﹤0.01% 262
2018
Q2
$6K Hold
135
﹤0.01% 245
2018
Q1
$6K Hold
135
﹤0.01% 243
2017
Q4
$7K Hold
135
﹤0.01% 250
2017
Q3
$7K Sell
135
-16
-11% -$779 ﹤0.01% 256
2017
Q2
$7K Sell
151
-92
-38% -$4.27K ﹤0.01% 264
2017
Q1
$11K Hold
243
﹤0.01% 252
2016
Q4
$12K Buy
243
+92
+61% +$4.22K ﹤0.01% 250
2016
Q3
$6K Hold
151
﹤0.01% 256
2016
Q2
$5K Hold
151
﹤0.01% 235
2016
Q1
$6K Hold
151
﹤0.01% 235
2015
Q4
$7K Hold
151
﹤0.01% 242
2015
Q3
$6K Hold
151
﹤0.01% 253
2015
Q2
$8K Hold
151
﹤0.01% 252
2015
Q1
$7K Hold
151
﹤0.01% 245
2014
Q4
$7K Buy
+151
New +$7.17K ﹤0.01% 250

Other funds holding MET

Isthmus Partners's MET Position: Q3 2021 in Review

Isthmus Partners sold out of MetLife (MET) in Q3 2021, closing a stake of 135 shares — an estimated $8K sold.

Isthmus Partners first reported a position in MET in Q4 2014 and held it in 18 quarters. The position peaked at $274K in Q1 2019. 1,105 funds tracked by Wall St. Rank hold MET as of Q3 2021.

  • Isthmus Partners reported no remaining MetLife position as of Q3 2021 after selling out during the quarter.
  • Isthmus Partners sold 135 MetLife shares in Q3 2021, an estimated $8K.
  • Isthmus Partners first reported a position in MetLife in Q4 2014 and held it in 18 quarters.
  • Isthmus Partners's MetLife position peaked at $274K in Q1 2019.
  • 1,105 funds tracked by Wall St. Rank held MetLife as of Q3 2021.

Based on Isthmus Partners's 13F filing for Q3 2021, filed 10 Nov 2021.